Dipexium Pharma (DPRX) will resume trading at 7:30am ET
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Wall Street closes higher as investors digest earnings, megacap outlook
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Raymond James Downgrades Dipexium Pharmaceuticals (DPRX) to Market Perform
October 26, 2016 7:33 AM EDTRaymond James downgraded Dipexium Pharmaceuticals (NASDAQ: DPRX) from Outperform to Market Perform and removed its price target.
For an analyst ratings summary and ratings history on Dipexium Pharmaceuticals click here. For more ratings news on Dipexium Pharmaceuticals click here.
Shares of Dipexium Pharmaceuticals closed at $2.80 yesterday.
... MoreDipexium Pharma (DPRX) Resumes Trading Following LUDP Halt
October 25, 2016 12:35 PM EDTDipexium Pharma (NASDAQ: DPRX) resumed trading after LUDP halt. Shares last down 76.5%, versus down 74% prior to halt.
... MoreDipexium Pharma (DPRX) Halted LUDP
October 25, 2016 12:28 PM EDTDipexium Pharma (NASDAQ: DPRX) halted LUDP with shares moving off session lows. Shares last down 74%
Dipexium Pharma (DPRX) trading halted with news pending
October 25, 2016 6:56 AM EDTDipexium Pharma (NASDAQ: DPRX) trading halted with news pending.
... More